Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market.
BACKGROUND
Sudden unexpected death in epilepsy (SUDEP) is possibly the most common cause of death as a result of complications from epilepsy. The need to educate and regularly review risk for all patients with epilepsy is paramount, but rarely delivered in actual clinical practice. Evidence suggests that education around SUDEP and modifiable risk variables translate into better self-management of epilepsy.


OBJECTIVE
We aimed to develop and implement an eHealth solution to support education and self-management of risks, in epilepsy.


METHODS
We undertook an innovation pathways approach, including problem identification, feasibility assessment, design, implementation, and marketing. People with epilepsy were provided a smartphone-based app (Epilepsy Self-Monitor, EpSMon), which translates the clinical risk assessment tool into an educational and self-monitoring platform, for the self-management of epilepsy.


RESULTS
Results include the success of the marketing campaign, and in what areas, with an estimated reach of approximately 38 million people. EpSMon has proved a success in academic and clinical circles, attracting awards and nominations for awards. The number of users of EpSMon, after 3 months, turned out to be lower than expected (N=221). A 4-month trial of the app in use in the United Kingdom, and the success of the marketing strategy, point to necessary changes to the model of delivery and marketing, summarized in this paper. These include the marketing message, user cost model, and need for the availability of an Android version.


CONCLUSIONS
EpSMon has proven a success in respect to its reception by academics, clinicians, stakeholder groups, and the patients who use it. There is work needed to promote the model and increase its acceptability/attractiveness, including broadening the marketing message, increasing its availability, and reducing its cost. Future development and promotion of the tool will hopefully inform iterative design of its core features for a receptive audience and lead to increased uptake as it is launched worldwide in 2016.
Neuro-Cognitive Research Group (NeuroCoRe), Plymouth University Peninsular School of Medicine and Dentistry (PUPSMD), Plymouth, United Kingdom. craig.newman@plymouth.ac.uk.
Craig
http://orcid.org/0000-0002-0525-8217
C
Newman
Rohit
http://orcid.org/0000-0002-1183-6933
R
Shankar
Jane
J
Hanna
Brendan
B
McLean
Alex
A
Osland
Cathryn
http://orcid.org/0000-0003-2237-353X
C
Milligan
Abbie
http://orcid.org/0000-0003-0932-3693
A
Ball
Caryn
http://orcid.org/0000-0002-2291-591X
C
Jory
Matthew
http://orcid.org/0000-0002-0812-0352
M
Walker
SUDEP; eHealth; epilepsy; mhealth; mobile app; self-management; self-monitoring; smartphone